Keytruda

Alkermes and Fred Hutch to work on Keytruda combination treatment

22-Oct-2019 By Vassia Barba

Alkermes to work collaboratively with the Fred Hutchinson Cancer Research Center on the clinical development of a drug candidate as a combination treatment alongside Keytruda.

Merck collaborates to examine Keytruda in combination with investigational drug

15-Aug-2019 By Maggie Lynch

Merck enters a clinical collaboration agreement with Oncologie to evaluate the combination of investigational drug Bavituximab and Keytruda in cancer patients.

Sales of Keytruda leads Merck to strong Q2

30-Jul-2019 By Ben Hargreaves

Sales of immunotherapy treatment, Keytruda, were up by 58% year-on-year, which led Merck to a sales increase of 12% overall compared to 2018.

Merck’s CEO: ‘Huge risk’ taken in drug development requires return

18-Jun-2019 By Vassia Barba

Kenneth Frazier argues that the current market dynamics are bringing treatments to patients and the industry does not ‘have to apologise for that.’

GSK indicates oncology intent with €3.7bn Merck deal

05-Feb-2019 By Ben Hargreaves

GSK moves to rebuild its oncology pipeline by partnering with Merck KGaA on an immuno-oncology drug candidate.

EMA gives positive opinion on Keytruda as adjuvant therapy

26-Oct-2018 By Maggie Lynch

MSD announced that the EMA’s CHMP has adopted a positive opinion recommending approval of Keytruda as an adjuvant therapy for the treatment of patients with melanoma.

MSD adds vaccine and biologics facility next to Keytruda site, creates 170 jobs

17-Oct-2018 By Flora Southey

MSD will build a second manufacturing plant in County Carlow, Ireland, in response to growing demand.

Daiichi-Merck partnership lines up Keytruda combo therapy

09-Oct-2018 By Maggie Lynch

Daiichi Sankyo announced it has entered into a clinical trial collaboration agreement with Merck & Co. to evaluate an investigational lung cancer treatment.